{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T05:19:11Z","timestamp":1769577551892,"version":"3.49.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["8P20GM103436"],"award-info":[{"award-number":["8P20GM103436"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["1R15MH094955"],"award-info":[{"award-number":["1R15MH094955"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/j.pbb.2015.01.007","type":"journal-article","created":{"date-parts":[[2015,1,17]],"date-time":"2015-01-17T07:05:28Z","timestamp":1421478328000},"page":"90-96","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Early-life risperidone administration alters maternal\u2013offspring interactions and juvenile play fighting"],"prefix":"10.1016","volume":"130","author":[{"given":"Matthew A.","family":"Gannon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clifford J.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel M.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Molly S.","family":"Griffith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecile A.","family":"Marczinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark E.","family":"Bardgett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2015.01.007_bb0005","series-title":"Atypical antipsychotics: from bench to bedside","first-page":"61","article-title":"Behavioral models of atypical antipsychotic drug action","author":"Bardgett","year":"2004"},{"key":"10.1016\/j.pbb.2015.01.007_bb0015","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S0893-133X(02)00376-7","article-title":"The effects of excitotoxic hippocampal lesions in rats on risperidone- and olanzapine-induced locomotor suppression","volume":"27","author":"Bardgett","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2015.01.007_bb0010","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1037\/a0031972","article-title":"Adult rats treated with risperidone during development are hyperactive","volume":"21","author":"Bardgett","year":"2013","journal-title":"Exp Clin Psychopharmacol"},{"key":"10.1016\/j.pbb.2015.01.007_bb0020","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/0091-3057(84)90194-1","article-title":"Suppression of play fighting by amphetamine: effects of catecholamine antagonists, agonists and synthesis inhibitors","volume":"20","author":"Beatty","year":"1984","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2015.01.007_bb0025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.bbr.2009.09.029","article-title":"Juvenile peer play experience and the development of the orbitofrontal and medial prefrontal cortices","volume":"207","author":"Bell","year":"2010","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2015.01.007_bb0030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0893-133X(94)00129-N","article-title":"Radioreceptor binding profile of the atypical antipsychotic olanzapine","volume":"14","author":"Bymaster","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2015.01.007_bb0035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.euroneuro.2008.08.010","article-title":"Effects of risperidone on glutamate receptor subtypes in developing rat brain","volume":"19","author":"Choi","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pbb.2015.01.007_bb0040","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.euroneuro.2009.09.002","article-title":"Effects of repeated risperidone exposure on serotonin receptor subtypes in developing rats","volume":"20","author":"Choi","year":"2010","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pbb.2015.01.007_bb0045","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1097\/JCP.0b013e3182549259","article-title":"Adverse effects of second-generation antipsychotics in children and adolescents: a Bayesian meta-analysis","volume":"32","author":"Cohen","year":"2012","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.pbb.2015.01.007_bb0050","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1089\/cap.2010.0068","article-title":"Early diagnoses and psychotherapeutic medication treatment experiences of a cohort of children under 6years old who received antipsychotic treatment in Florida's Medicaid program","volume":"21","author":"Constantine","year":"2011","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.pbb.2015.01.007_bb0055","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.dcn.2011.07.001","article-title":"Double helix: reciprocity between juvenile play and brain development","volume":"1","author":"Cooke","year":"2011","journal-title":"Dev Cogn Neurosci"},{"key":"10.1016\/j.pbb.2015.01.007_bb0060","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0165-3806(85)90004-5","article-title":"Ontogeny of tolerance to haloperidol: behavioral and biochemical measures","volume":"355","author":"Coyle","year":"1985","journal-title":"Brain Res"},{"key":"10.1016\/j.pbb.2015.01.007_bb0065","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/BF00432686","article-title":"Enduring behavioural and biochemical effects in the adult rat after prolonged postnatal administration of haloperidol","volume":"74","author":"Cuomo","year":"1981","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2015.01.007_bb0070","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00427270","article-title":"Behavioural and biochemical effects in the adult rat after prolonged postnatal administration of clozapine","volume":"81","author":"Cuomo","year":"1983","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2015.01.007_bb0075","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1176\/ps.2008.59.5.507","article-title":"Who are the new users of antipsychotic medications?","volume":"59","author":"Domino","year":"2008","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.pbb.2015.01.007_bb0080","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0091-3057(85)90043-7","article-title":"Interactive effects of caffeine, 2-chloroadenosine and haloperidol on activity, social investigation and play fighting of juvenile rats","volume":"22","author":"Holloway","year":"1985","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pbb.2015.01.007_bb0085","first-page":"CD005040","article-title":"Risperidone for autism spectrum disorder","volume":"1","author":"Jesner","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pbb.2015.01.007_bb0090","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1176\/ajp.156.2.286","article-title":"Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia","volume":"156","author":"Kapur","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.pbb.2015.01.007_bb0095","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1124\/jpet.102.046987","article-title":"Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy","volume":"305","author":"Kapur","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pbb.2015.01.007_bb0100","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s10803-012-1723-5","article-title":"Risperidone dosing in children and adolescents with autistic disorder: a double-blind, placebo-controlled study","volume":"43","author":"Kent","year":"2013","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.pbb.2015.01.007_bb0105","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1177\/0883073810382143","article-title":"Risperidone use in autism spectrum disorders: a retrospective review of a clinic-referred patient population","volume":"26","author":"Lemmon","year":"2011","journal-title":"J Child Neurol"},{"key":"10.1016\/j.pbb.2015.01.007_bb0110","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0378-4347(93)80327-Z","article-title":"Determination of risperidone and 9-hydroxyrisperidone in human plasma by high-performance liquid chromatography with electrochemical detection","volume":"614","author":"LeMoing","year":"1993","journal-title":"J Chromatogr"},{"key":"10.1016\/j.pbb.2015.01.007_bb0115","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.schres.2004.09.012","article-title":"Effects of chronic typical and atypical antipsychotic drug treatment on maternal behavior in rats","volume":"75","author":"Li","year":"2005","journal-title":"Schizophr Res"},{"key":"10.1016\/j.pbb.2015.01.007_bb0120","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.bbr.2011.03.062","article-title":"Administration of clozapine to a mother rat potentiates pup ultrasonic vocalization in response to separation and re-separation: contrast with haloperidol","volume":"222","author":"Li","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2015.01.007_bb0125","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1146\/annurev.neuro.24.1.1161","article-title":"Maternal care, gene expression, and the transmission of individual differences in stress reactivity across generations","volume":"24","author":"Meaney","year":"2001","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.pbb.2015.01.007_bb0130","doi-asserted-by":"crossref","first-page":"103","DOI":"10.31887\/DCNS.2005.7.2\/mmeaney","article-title":"Environmental programming of stress responses through DNA methylation: life at the interface between a dynamic environment and a fixed genome","volume":"7","author":"Meaney","year":"2005","journal-title":"Dialogues Clin Neurosci"},{"key":"10.1016\/j.pbb.2015.01.007_bb0135","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.euroneuro.2006.10.004","article-title":"Effects of risperidone on dopamine receptor subtypes in developing rat brain","volume":"17","author":"Moran-Gates","year":"2007","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pbb.2015.01.007_bb0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00429171","article-title":"Dopaminergic supersensitivity after neuroleptics: time-course and specificity","volume":"60","author":"Muller","year":"1978","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2015.01.007_bb0145","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/archgenpsychiatry.2012.647","article-title":"National trends in the office-based treatment of children, adolescents, and adults with antipsychotics","volume":"69","author":"Olfson","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pbb.2015.01.007_bb0150","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ejphar.2008.02.005","article-title":"Using pharmacokinetic\u2013pharmacodynamic modeling as a tool for prediction of therapeutic effective plasma levels of antipsychotics","volume":"584","author":"Olsen","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pbb.2015.01.007_bb0155","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/dev.20342","article-title":"The influence of natural variations in maternal care on play fighting in the rat","volume":"50","author":"Parent","year":"2008","journal-title":"Dev Psychobiol"},{"key":"10.1016\/j.pbb.2015.01.007_bb0160","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0149-7634(95)00060-7","article-title":"Multiple differences in the play fighting of male and female rats. Implications for the causes and functions of play","volume":"21","author":"Pellis","year":"1997","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pbb.2015.01.007_bb0165","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00213-010-2015-4","article-title":"Effect of the adenosine A2A receptor antagonist MSX-3 on motivational disruptions of maternal behavior induced by dopamine antagonism in the early postpartum rat","volume":"213","author":"Pereira","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2015.01.007_bb0170","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/j.1469-7998.1976.tb02294.x","article-title":"An investigation of individual, age and sexual differences in the play of Rattus norvegicus","volume":"179","author":"Poole","year":"1976","journal-title":"J Zool (Lond)"},{"key":"10.1016\/j.pbb.2015.01.007_bb0175","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/0031-9384(86)90262-3","article-title":"Prenatal stress eliminates differential maternal attention to male offspring in Norway rats","volume":"38","author":"Power","year":"1986","journal-title":"Physiol Behav"},{"key":"10.1016\/j.pbb.2015.01.007_bb0180","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s10803-012-1689-3","article-title":"Brief Report: Social disability in autism spectrum disorder: results from Research Units on Pediatric Psychopharmacology (RUPP) autism network trials","volume":"43","author":"Scahill","year":"2013","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/j.pbb.2015.01.007_bb0185","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF00428186","article-title":"Chronic haloperidol during development attenuates dopamine autoreceptor function in striatal and mesolimbic brain regions of young and older adult rats","volume":"85","author":"Scalzo","year":"1985","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2015.01.007_bb0190","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF02245606","article-title":"Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding","volume":"124","author":"Schotte","year":"1996","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2015.01.007_bb0200","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.neubiorev.2011.03.006","article-title":"In search of the neurobiological substrates for social playfulness in mammalian brains","volume":"35","author":"Siviy","year":"2011","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pbb.2015.01.007_bb0195","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.bbr.2011.02.009","article-title":"Dysfunctional play and dopamine physiology in the Fischer 344 rat","volume":"220","author":"Siviy","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2015.01.007_bb0205","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0149-7634(00)00014-2","article-title":"The adolescent brain and age-related behavioral manifestations","volume":"24","author":"Spear","year":"2000","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.pbb.2015.01.007_bb0210","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/schbul\/sbr006","article-title":"Chronic treatment with aripiprazole prevents development of dopamine supersensitivity and potentially supersensitivity psychosis","volume":"38","author":"Tadokoro","year":"2012","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.pbb.2015.01.007_bb0215","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1037\/h0077816","article-title":"Fighting in juvenile rats and the ontogeny of agonistic behavior","volume":"94","author":"Taylor","year":"1980","journal-title":"J Comp Physiol Psychol"},{"key":"10.1016\/j.pbb.2015.01.007_bb0225","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF02245444","article-title":"Regional brain distribution of risperidone and its active metabolite 9-hydroxy-risperidone in the rat","volume":"114","author":"van Beijsterveldt","year":"1994","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pbb.2015.01.007_bb0230","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.bbr.2007.11.024","article-title":"Social interactions in adolescent and adult Sprague\u2013Dawley rats: impact of social deprivation and test context familiarity","volume":"188","author":"Varlinskaya","year":"2008","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pbb.2015.01.007_bb0235","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.euroneuro.2009.04.008","article-title":"Antipsychotics in children and adolescents: increasing use, evidence for efficacy and safety concerns","volume":"19","author":"Vitiello","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pbb.2015.01.007_bb0220","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejphar.2007.09.010","article-title":"Antipsychotic-induced suppression of locomotion in juvenile, adolescent and adult rats","volume":"578","author":"Wiley","year":"2008","journal-title":"Eur J Pharmacol"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305715000180?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305715000180?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T02:14:49Z","timestamp":1690856089000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305715000180"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3]]},"references-count":47,"alternative-id":["S0091305715000180"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2015.01.007","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early-life risperidone administration alters maternal\u2013offspring interactions and juvenile play fighting","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2015.01.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}